Javascript is required to run this page

HB333

Prescription Monitoring Program; requirements of prescribers, exceptions.

Status:
Killed

Chief Patron:
David Yancey (R)

Session:
2018 Regular Session

Summary

As Introduced. Prescription Monitoring Program; requirements of prescribers; exceptions.

Provides that a prescriber initiating a new course of treatment to a human patient that includes the prescribing of opioids, anticipated at the onset of treatment to last more than seven consecutive days, shall not be required to request information about the patient from the Prescription Monitoring Program if the purpose of the prescription is the management of pain associated with cancer. (Less)
  • Bill History

  • 01/04/2018 - House: Prefiled and ordered printed; offered 01/10/18 18103337D
  • 01/04/2018 - House: Referred to Committee on Health, Welfare and Institutions
  • 01/15/2018 - House: Assigned HWI sub: Subcommittee #2
  • 01/23/2018 - House: Subcommittee recommends passing by indefinitely (10-Y 0-N)
  • 01/25/2018 - House: Impact statement from VDH (HB333)
  • 02/13/2018 - House: Left in Health, Welfare and Institutions